[Al-khiyal]

".....Within the cognitive disorders area, sales of Tanakan(R) for the second quarter of 2007 reached EUR 33.1 million, up 1.3% year-on-year (second quarter 2006, EUR 32.7 million). Strong growth in Algeria, Vietnam, Russia, Romania and China were almost fully offset by the sales decrease in France, which represented 68.3% of total Tanakan(R) sales in the second quarter 2007 compared with 69.6% a year earlier. For the first half 2007, sales of Tanakan(R) amounted to EUR 64.1 million down 0.6% mainly due to decreasing volumes in France....."

Ipsen's first half 2007 sales and outlook for the second half 2007